{
    "startDate": "2020-01-01",
    "endDate": "2020-09-30",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "EYES",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2437000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 872000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 3309000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 193000
            },
            {
                "label": "Represents the information pertaining to deposits and other assets.",
                "concept": "eyes:DepositsAndOtherAssets",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 3522000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 285000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1260000
            },
            {
                "label": "Accrued compensation expense",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 393000
            },
            {
                "label": "Represents information pertaining to accrued clinical trial expenses.",
                "concept": "eyes:AccruedClinicalTrialExpenses",
                "unit": "usd",
                "value": 707000
            },
            {
                "label": "Contract liabilities",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 335000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2980000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 2980000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, no par value, 10,000 shares authorized; none outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, no par value; 300,000 shares authorized; shares issued and outstanding: 23,118 and 15,643 as of September 30, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 270126000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 49287000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -498000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 542000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 3522000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13589000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 148000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 394000
            },
            {
                "label": "Non-cash lease expense",
                "concept": "OperatingLeaseExpense",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Restructuring charges-inventory and fixed asset impairment",
                "concept": "RestructuringCostsAndAssetImpairmentCharges",
                "unit": "usd",
                "value": 1116000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -461000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -218000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 568000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1256000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 64000
            },
            {
                "label": "Accrued compensation expenses",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -2360000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -15369000
            },
            {
                "label": "Cash inflow from disposal of assets which were held for sale.",
                "concept": "eyes:ProceedsFromSaleOfAssetsHeldForSale",
                "unit": "usd",
                "value": 398000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 331000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 67000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants.",
                "concept": "eyes:ProceedsFromIssuanceOfCommonStockAndWarrants",
                "unit": "usd",
                "value": 6679000
            },
            {
                "label": "Repurchase of ESPP shares and fractional shares in connection with reverse stock split.",
                "concept": "eyes:RepurchaseOfESPPSharesAndFractionalSharesInConnectionWithReverseStockSplit",
                "unit": "usd",
                "value": 281000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 6398000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Net increase (decrease)",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -8890000
            },
            {
                "label": "Fair value of warrants issued in connection with issuance of common stock.",
                "concept": "eyes:FairValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock",
                "unit": "usd",
                "value": 280000
            }
        ],
        "ic": [
            {
                "label": "Research and development, net of grants",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 4489000
            },
            {
                "label": "Clinical and regulatory expense, net of grants.",
                "concept": "eyes:ClinicalAndRegulatoryExpenseNetOfGrants",
                "unit": "usd",
                "value": 1604000
            },
            {
                "label": "Selling and marketing",
                "concept": "SellingAndMarketingExpense",
                "unit": "usd",
                "value": 701000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 4599000
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 2229000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 13622000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -13622000
            },
            {
                "label": "Miscellaneous income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 33000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13589000
            },
            {
                "label": "Net loss per common share \u2013 basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.69
            },
            {
                "label": "Weighted average common shares outstanding \u2013 basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 19714000
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 64000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -13525000
            }
        ]
    }
}